Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival.

ABSTRACT:

Background

National organizations have recommended quality measures for operations in early-stage non-small cell lung cancer (NSCLC). The outcomes of adherence to these guidelines are unknown.

Methods

Information about patients who underwent an operation for clinical stage I NSCLC was abstracted from the National Cancer Database. After reviewing current guidelines, the following quality measures were selected: anatomic resection, operation within 8 weeks of diagnosis, achievement of negative surgical margins, and sampling of 10 or more lymph nodes. Multivariate models identified variables independently associated with receiving quality measures and a Cox model created to evaluate overall survival.

Results

Between 2004 and 2013, 133,026 of 133,366 (99.7%), 126,598 of 1

SUBMITTER: Samson P 

PROVIDER: S-EPMC5182109 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature